List of Excipients in API lenalidomide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lenalidomide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Celgene Corporation | REVLIMID | lenalidomide | 59572-402 | ANHYDROUS LACTOSE | |
| Celgene Corporation | REVLIMID | lenalidomide | 59572-402 | CELLULOSE, MICROCRYSTALLINE | |
| Celgene Corporation | REVLIMID | lenalidomide | 59572-402 | CROSCARMELLOSE SODIUM | |
| Celgene Corporation | REVLIMID | lenalidomide | 59572-402 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing lenalidomide
Detailed excipient profiles for lenalidomide
Excipient focus: AMMONIA
lenalidomide drug variants containing AMMONIA
lenalidomide drug variants not containing AMMONIA
Excipient focus: ANHYDROUS LACTOSE
lenalidomide drug variants containing ANHYDROUS LACTOSE
lenalidomide drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1935 |
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1936 |
| Dr Reddy's Laboratories Inc | lenalidomide | 43598-516 |
| Sun Pharmaceutical Industries Inc | lenalidomide | 63304-042 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
lenalidomide drug variants containing CELLULOSE, MICROCRYSTALLINE
lenalidomide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lenalidomide | 0480-1241 |
| Teva Pharmaceuticals Inc | lenalidomide | 0480-1242 |
| Aurobindo Pharma Limited | lenalidomide | 59651-342 |
| Cipla USA Inc | lenalidomide | 69097-604 |
| EXELAN PHARMACEUTICALS INC | lenalidomide | 76282-696 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
lenalidomide drug variants containing CROSCARMELLOSE SODIUM
lenalidomide drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | lenalidomide | 0480-1241 |
| Teva Pharmaceuticals Inc | lenalidomide | 0480-1242 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
lenalidomide drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | lenalidomide | 47781-483 |
| Alvogen Inc | lenalidomide | 47781-484 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
lenalidomide drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1935 |
| Dr Reddy's Laboratories Inc | lenalidomide | 43598-516 |
| Aurobindo Pharma Limited | lenalidomide | 59651-342 |
| Cipla USA Inc | lenalidomide | 69097-604 |
| EXELAN PHARMACEUTICALS INC | lenalidomide | 76282-696 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 3
lenalidomide drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | lenalidomide | 47781-483 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
lenalidomide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | lenalidomide | 47781-483 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
lenalidomide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | lenalidomide | 47781-484 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
lenalidomide drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | lenalidomide | 31722-257 |
| Alvogen Inc | lenalidomide | 47781-483 |
| Alvogen Inc | lenalidomide | 47781-484 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
lenalidomide drug variants containing FERRIC OXIDE YELLOW
lenalidomide drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
lenalidomide drug variants containing FERROSOFERRIC OXIDE
lenalidomide drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | lenalidomide | 59572-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
lenalidomide drug variants containing GELATIN
lenalidomide drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | lenalidomide | 59572-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
lenalidomide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | lenalidomide | 63304-042 |
| Zydus Pharmaceuticals USA Inc | lenalidomide | 70710-1031 |
| Zydus Lifesciences Limited | lenalidomide | 70771-1677 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
lenalidomide drug variants containing MAGNESIUM STEARATE
lenalidomide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1935 |
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1936 |
| Teva Pharmaceuticals Inc | lenalidomide | 0480-1241 |
| Teva Pharmaceuticals Inc | lenalidomide | 0480-1242 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
lenalidomide drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | lenalidomide | 43598-516 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
lenalidomide drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | lenalidomide | 59651-342 |
| Cipla USA Inc | lenalidomide | 69097-604 |
| EXELAN PHARMACEUTICALS INC | lenalidomide | 76282-696 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POTASSIUM HYDROXIDE
lenalidomide drug variants containing POTASSIUM HYDROXIDE
lenalidomide drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | lenalidomide | 47781-483 |
| Alvogen Inc | lenalidomide | 47781-484 |
| Celgene Corporation | lenalidomide | 59572-402 |
| Apotex Corp | lenalidomide | 60505-4533 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
lenalidomide drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | lenalidomide | 43598-516 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing POVIDONE
Excipient focus: PROPYLENE GLYCOL
lenalidomide drug variants containing PROPYLENE GLYCOL
lenalidomide drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | lenalidomide | 47781-483 |
| Alvogen Inc | lenalidomide | 47781-484 |
| Celgene Corporation | lenalidomide | 59572-402 |
| Aurobindo Pharma Limited | lenalidomide | 59651-342 |
| Zydus Pharmaceuticals USA Inc | lenalidomide | 70710-1031 |
| Zydus Lifesciences Limited | lenalidomide | 70771-1677 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
lenalidomide drug variants containing SHELLAC
lenalidomide drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | lenalidomide | 59572-402 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
lenalidomide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1935 |
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1936 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STEARYL FUMARATE
lenalidomide drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1935 |
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1936 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
lenalidomide drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1935 |
| Mylan Pharmaceuticals Inc | lenalidomide | 0378-1936 |
| >Company | >Ingredient | >NDC |
lenalidomide drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
lenalidomide drug variants containing TITANIUM DIOXIDE
lenalidomide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Celgene Corporation | lenalidomide | 59572-402 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
